Pure Bioscience Stock Volatility
| PURE Stock | USD 0.08 0.0013 1.62% |
Pure Bioscience exhibits a high volatility profile over the current measurement period. Pure Bioscience registers a Sharpe Ratio (Efficiency) of 0.14, indicating measured return efficiency over the last 3 months. We identified 23 technical signals influencing current risk dynamics.
Sharpe Ratio = 0.1378
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PURE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Pure Bioscience (PURE) recorded a Market Risk Adjusted Performance of 3.4%, a Risk of 8.30, and a Risk Adjusted Performance of 0.1%. At about 10% of its historical trend bandwidth, Pure Bioscience is operating within prior boundaries. Its impact depends on correlation and volatility interaction.
Key indicators related to Pure Bioscience's volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Managing volatility risk for Pure Bioscience positions requires understanding whether Pure Bioscience's elevated volatility is driven by fundamental changes or temporary market sentiment. Fundamental-driven volatility for Pure Bioscience tends to persist longer than sentiment-driven spikes.
Pure |
Volatility Strategy
Pure Bioscience return swings may impact long-term portfolio variance. Current statistical measures show total volatility near 8.3% with a beta coefficient of 0.31, indicating sensitivity relative to the broader market benchmark. Risk-adjusted efficiency, represented by a Sharpe ratio of 0.14, evaluates return per unit of total risk. An alpha value of 1.06 reflects performance relative to systematic market exposure. Expected return estimates near 1.14% are derived from historical distribution modeling and help frame forward-looking return assumptions within a portfolio context. Risk appetite shifts can affect dispersion levels.
Main indicators related to Pure Bioscience's market risk premium analysis include:
Beta 0.31 | Alpha 1.06 | Risk 8.3 | Sharpe Ratio 0.14 | Expected Return 1.14 |
Moving together with Pure OTC Stock
Moving against Pure OTC Stock
| 0.78 | AXP | American Express | PairCorr |
| 0.77 | DIS | Walt Disney | PairCorr |
| 0.72 | JPM | JPMorgan Chase | PairCorr |
| 0.57 | MMM | 3M Company | PairCorr |
| 0.55 | MSFT | Microsoft | PairCorr |
| 0.47 | AMZN | Amazon Inc | PairCorr |
| 0.44 | GOOG | Alphabet Class C | PairCorr |
| 0.39 | BA | Boeing | PairCorr |
| 0.38 | AAPL | Apple Inc | PairCorr |
| 0.31 | META | Meta Platforms | PairCorr |
Sensitivity To Market
Pure Bioscience demonstrates a beta of 0.31, indicating market-linked volatility exposure. Regression slope interpretation supports this systematic risk estimate. Total volatility measures approximately 8.3%.Pure Bioscience volatility can be described using downside deviation (0.0%), which captures negative-return intensity over the selected horizon. For stocks, volatility can be sensitive to changes in rates, inflation expectations, and overall market tone.
3 Months Beta |Analyze Pure Bioscience Demand TrendCheck current 90 days Pure Bioscience correlation with market (Dow Jones Industrial)Downside Risk
Pure standard deviation quantifies the magnitude of daily price swings relative to the average over the selected period. More volatile instruments exhibit higher standard deviations. This measure counts all price dispersion as risk, including returns above the mean.
Standard Deviation | 8.3 |
Standard deviation of Pure Bioscience captures both favorable and adverse price swings. Downside deviation and semi-deviation focus exclusively on the adverse side of Pure Bioscience's return distribution. Pure Bioscience (PURE) recorded a Maximum Drawdown of 45.
OTC Stock Volatility Analysis
Volatility is a core concept when evaluating Pure Bioscience as part of a diversified portfolio. The otc stock's historical price swings give investors a sense of how much risk Pure Bioscience's adds. Combining Pure Bioscience with lower-volatility assets can reduce overall portfolio risk.
Transformation |
This analysis covers sixty-one data points across the selected time horizon. Pure Bioscience Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Projected Return Density Against Market
Given the investment horizon of 90 days Pure Bioscience has a beta of 0.3062 indicating as returns on the market go up, Pure Bioscience's average returns are expected to increase less than the benchmark. However, during a bear market, the loss from holding Pure Bioscience is expected to be smaller as well.Market risk ties Pure Bioscience to macro cycles, whereas company or sector-specific developments represent independent drivers. Volatility metrics help measure this balance. Pure Bioscience (PURE) recorded a Mean Deviation of 4.02 and a Standard Deviation of 7.91.
Predicted Return Density |
| Returns |
What Drives Pure Bioscience's Price Volatility?
Several factors can influence Pure Bioscience's market volatility:Industry Dynamics
Sector-level events can directly affect Pure Bioscience's price stability. Regulatory changes, supply disruptions, or shifts in demand within Pure Bioscience's industry may create volatility even when the broader market is calm. Competitive dynamics and industry consolidation can also amplify price swings for companies like Pure Bioscience.Political and Economic Environment
Macroeconomic conditions and policy decisions shape the backdrop for Pure Bioscience's price movements. Interest rate changes, trade policy shifts, and fiscal legislation can all alter investor sentiment toward Pure Bioscience. During periods of economic expansion, Pure Bioscience's price tends to benefit from broader market optimism, while downturns can amplify selling pressure.Pure Bioscience's Company-Specific Factors
Volatility can also stem from events unique to Pure Bioscience. Earnings surprises, management changes, product launches, or legal developments may trigger sharp price reactions in Pure Bioscience's stock. Conversely, operational setbacks, guidance revisions, or data breaches can weigh on Pure Bioscience's share price.OTC Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Pure Bioscience is 725.62. The daily returns are distributed with a variance of 68.89 and standard deviation of 8.3. The mean deviation of Pure Bioscience is currently at 4.39. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.8
α | Alpha over Dow Jones | 1.06 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 8.30 | |
Ir | Information ratio | 0.14 |
OTC Stock Return Volatility
Pure Bioscience daily volatility tracks how widely otc returns have moved around the mean across the selected time frame. The firm reflects 8.2997% volatility on return distribution over a 90-day horizon. On the other hand, Dow Jones Industrial has volatility of 0.8255% on return distribution over a 90-day investment horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Surface-level performance for Pure OTC Stock can mask how the business actually stacks up against its competitive set. Without reviewing risk-adjusted indicators, investors may overweight recent returns and underweight the volatility required to achieve them. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EXDW | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TNYBF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HERB | 17.52 | 2.80 | 0.08 | 0.71 | 17.11 | 76.54 | 123.69 | |||
| DQWS | 1.19 | -0.16 | 0.00 | -0.23 | 0.00 | 0.00 | 20.51 | |||
| INDFY | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NPRFF | 4.63 | -0.05 | 0.02 | -0.05 | 6.38 | 9.01 | 42.77 | |||
| CAWW | 1.58 | -0.31 | 0.00 | -0.57 | 0.00 | 2.00 | 27.41 | |||
| NUVI | 10.15 | 4.64 | 0.00 | 1.49 | 0.00 | 33.00 | 199.43 | |||
| LNLHF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HIGR | 8.44 | -0.53 | 0.00 | -0.04 | 0.00 | 0.83 | 209.39 |
Risk Metrics, Assumptions & Methodology
Volatility for Pure Bioscience measures return dispersion and uncertainty over time. Uncertainty impacts position sizing assumptions in portfolio models. Pure Bioscience has a market cap of 13.36 M, P/E of 12.49, ROE of -128.79%.
Macroaxis compiles Pure Bioscience metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Not all fields update in real time. Volatility and downside metrics are estimated from historical return dispersion.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardPure Bioscience Investment Opportunity
Recent data suggests that Pure Bioscience is meaningfully more volatile than Dow Jones Industrial, by roughly a 10.0x factor. The higher-risk profile should usually be reviewed beside Sharpe Ratio, downside risk, and catalyst strength before the position is sized up.You can use Pure Bioscience to enhance the returns of your portfolios. This move summary looks at how the current session may translate into a basic near-term setup. It is intended to separate routine noise from more speculative bursts in price action. a large bullish trend. Check odds of Pure Bioscience to be traded at $0.0894 in 90 days.Excellent diversification
For the present investment horizon, the measured correlation between PURE and DJI stands at -0.66, or Excellent diversification. The overlap area represents the portion of risk that may be diversified away when both instruments are held together and nothing else in the portfolio changes.
Pure Bioscience Additional Risk Indicators
Risk analysis around Pure Bioscience becomes more useful when investors review secondary indicators that can confirm, refine, or challenge the basic volatility picture. This is most useful when investors want to understand whether the current opportunity is being paid for with reasonable risk.
| Risk Adjusted Performance | 0.1135 | |||
| Market Risk Adjusted Performance | 3.37 | |||
| Mean Deviation | 4.02 | |||
| Coefficient Of Variation | 761.12 | |||
| Standard Deviation | 7.91 | |||
| Variance | 62.64 | |||
| Information Ratio | 0.141 |
Pure Bioscience Suggested Diversification Pairs
Pair analysis around Pure Bioscience matters because it can turn one security idea into a more market-neutral structure. This framework is most useful when investors want to hedge directional moves caused by sector headlines or broad market pressure.
Pair strategies help manage risk, but investors should recognize that not all risk can be diversified away through pairing. Market-level risk for Pure Bioscience persists even in a well-constructed pair. The benefit is in offsetting Pure Bioscience's company-specific risk, which can be meaningfully reduced by selecting a second position that moves independently of Pure Bioscience.
Popular Tools for Pure OTC Stock analysis
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |